TNF and Opportunistic infection: Although risks have been observed mostly in patients using anti-tumor necrosis factor (anti-TNF) therapy, the risks of AEs are considered to be increased when using biologics in combination with corticosteroids or other immunosuppressive agents,4–6 with risk of opportunistic infections also linked to concomitant corticosteroids.7